Primera Therapeutics
PrivateLast Round
Accelerator
Dec 29, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Primera Therapeutics operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was an Accelerator round in December 2022.
Primera Therapeutics is a biotechnology company that develops gene editing therapies to treat mitochondrial diseases by targeting inherited mutant mitochondrial DNA.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Primera Therapeutics Comparables
Compare Primera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latus Bio | 78% | |
| Capsida Biotherapeutics | 78% | |
| Prime Medicine | 74% |
For institutional investors. Book with your work email.
Primera Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Primera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hibiscus BioVentures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 682% MoM, from 49 to 383.
- May 2, 2025
Monthly visitors increased 513% MoM.
For institutional investors. Book with your work email.
Primera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Primera Therapeutics's valuation, stock price, and market status.
Is Primera Therapeutics a public or private company?
Primera Therapeutics is a private company.
What is the current stock price of Primera Therapeutics?
Primera Therapeutics is a private company, so its shares have no public market price. Caplight tracks Primera Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Primera Therapeutics worth (valuation)?
Valuation information for Primera Therapeutics is not publicly available.
Can I buy Primera Therapeutics stock?
Primera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Primera Therapeutics's last funding round?
Primera Therapeutics's most recent funding round was Accelerator on December 29, 2022.
Who are the main investors in Primera Therapeutics?
Key investors in Primera Therapeutics include Hibiscus BioVentures.
Will Primera Therapeutics IPO soon?
No public IPO plans have been announced for Primera Therapeutics.
How can I track Primera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Primera Therapeutics's shares on secondary markets.